Valuation: Jubilant Ingrevia Limited

Capitalization 113B 1.18B 1B 920M 871M 1.61B 1.63B 10.96B 4.27B 53.41B 4.41B 4.32B 186B P/E ratio 2026 *
40.3x
P/E ratio 2027 * 30.1x
Enterprise value 121B 1.26B 1.08B 989M 936M 1.73B 1.75B 11.78B 4.59B 57.39B 4.74B 4.64B 199B EV / Sales 2026 *
2.77x
EV / Sales 2027 * 2.37x
Free-Float
48.68%
Yield 2026 *
0.75%
Yield 2027 * 0.77%
1 day-3.57%
1 week-0.43%
Current month+0.17%
1 month+10.15%
3 months+6.62%
6 months+7.33%
Current year+1.48%
1 week 690
Extreme 690
767.2
1 month 620.75
Extreme 620.75
767.2
Current year 535.3
Extreme 535.3
776.4
1 year 535.3
Extreme 535.3
851.85
3 years 379.2
Extreme 379.2
884.95
5 years 350.8
Extreme 350.8
884.95
10 years 243.6
Extreme 243.6
884.95
Manager TitleAgeSince
Chief Executive Officer 45 2023-09-30
Director of Finance/CFO - 2024-08-11
Chief Operating Officer 27 2022-03-28
Director TitleAgeSince
Chairman 73 2021-02-05
Chairman 69 2021-02-05
Director/Board Member 76 2021-02-05
Change 5d. change 1-year change 3-years change Capi.($)
-3.57%-0.43% - - 1.23B
+0.24%-1.52%-0.38%+44.47% 70.67B
+0.33%0.00%-31.40%-13.23% 32.69B
-1.79%-1.68%-32.35%-44.14% 29.45B
+1.30%+5.44%+171.46%+32.72% 26.68B
-2.13%+7.78%+254.77%+3.53% 24.77B
+8.02%+14.76%+1.98%+29.26% 23.25B
-0.97%-0.60%+12.86%-8.24% 20.13B
-6.79%-2.25%+116.60%-13.43% 16.95B
-0.42%+3.11%+16.99%+64.96% 13.3B
Average -0.61%+0.82%+56.73%+10.66% 28.66B
Weighted average by Cap. -0.05%+0.46%+44.15%+13.66%

Financials

2026 *2027 *
Net sales 43.74B 457M 390M 357M 338M 627M 633M 4.26B 1.66B 20.75B 1.71B 1.68B 72.08B 51.3B 536M 457M 419M 397M 735M 742M 4.99B 1.94B 24.33B 2.01B 1.97B 84.54B
Net income 2.79B 29.14M 24.86M 22.8M 21.58M 39.99M 40.37M 272M 106M 1.32B 109M 107M 4.6B 3.75B 39.19M 33.42M 30.65M 29.01M 53.77M 54.28M 365M 142M 1.78B 147M 144M 6.18B
Net Debt 8.39B 87.62M 74.73M 68.54M 64.88M 120M 121M 816M 318M 3.98B 329M 322M 13.82B 9.04B 94.41M 80.52M 73.85M 69.9M 130M 131M 880M 343M 4.29B 354M 347M 14.89B
Logo Jubilant Ingrevia Limited
Jubilant Ingrevia Limited is a vertically integrated provider of life sciences products and solutions. Its segments include Specialty chemicals, Nutrition & Health solutions and Chemical intermediates. The Specialty Chemicals segment includes bio-pyridine & bio-picolines, fine chemicals, agro chemicals, custom development and manufacturing organization, and microbial control solutions. The Nutrition & Health solutions segment includes nutrition and health ingredients and animal and human nutrition health solutions. The Chemical Intermediates segment includes acetyls and specialty ethanol. In agro chemicals, it offers value-added derivatives, derived from specialty building blocks such as pyridine, picoline and diketene derivatives. This sub-segment includes insecticides, herbicides and fungicides. Its product portfolio includes vital nutritional ingredients, including Vitamin B3, Vitamin B4, Picolinates, and premix formulations designed for both animal and human nutrition.
Employees
2,139
Date Price Change Volume
26-05-12 714.45 -3.57% 18,854
26-05-11 740.90 -0.40% 23,224
26-05-08 743.85 -1.38% 6,380
26-05-07 754.25 +1.56% 19,047
26-05-06 742.65 +2.29% 9,057
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
6
Last Close Price
712.15INR
Average target price
919.50INR
Spread / Average Target
+29.12%

Quarterly revenue - Rate of surprise